Ophthotech reports plans to price its initial public offering of stock

Morgan Stanley, JPMorgan, Leerink Swann and Stifel assist with sale

By Devika Patel

Knoxville, Tenn., Aug. 15 - Ophthotech Corp. will conduct an initial public offering of its common stock with a greenshoe, according to a Form S-1 filed Wednesday with the Securities and Exchange Commission.

Morgan Stanley and J.P. Morgan are the joint bookrunning managers. Leerink Swann and Stifel are the co-managers.

Proceeds will be used for clinical trials and development, working capital and other general corporate purposes.

The biopharmaceutical company is based in New York. It intends to list its common stock on the Nasdaq under the symbol "OPHD."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.